Sure it is. I've had this on my tracking list for years as well. The co. appears to be waiting for some sales momentum, which may be due to adoption issues and the small size of the sales staff. Any advance in the science in treating BPH is going to be a tough sell when a patient is confronted with the choice of taking a pill or allowing someone to cath them. That said, if the procedure is as painless as the co. reports, it will continue to gain advocates.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.